GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » China Biotech Services Holdings Ltd (HKSE:08037) » Definitions » Days Payable

China Biotech Services Holdings (HKSE:08037) Days Payable : 19.65 (As of Dec. 2023)


View and export this data going back to 2004. Start your Free Trial

What is China Biotech Services Holdings Days Payable?

China Biotech Services Holdings's average Accounts Payable for the three months ended in Dec. 2023 was HK$5.8 Mil. China Biotech Services Holdings's Cost of Goods Sold for the three months ended in Dec. 2023 was HK$26.9 Mil. Hence, China Biotech Services Holdings's Days Payable for the three months ended in Dec. 2023 was 19.65.

The historical rank and industry rank for China Biotech Services Holdings's Days Payable or its related term are showing as below:

HKSE:08037' s Days Payable Range Over the Past 10 Years
Min: 27.52   Med: 82.85   Max: 218.01
Current: 153.44

During the past 13 years, China Biotech Services Holdings's highest Days Payable was 218.01. The lowest was 27.52. And the median was 82.85.

HKSE:08037's Days Payable is ranked better than
70.59% of 204 companies
in the Medical Diagnostics & Research industry
Industry Median: 66.645 vs HKSE:08037: 153.44

China Biotech Services Holdings's Days Payable declined from Dec. 2022 (89.22) to Dec. 2023 (19.65). It may suggest that China Biotech Services Holdings accelerated paying its suppliers.


China Biotech Services Holdings Days Payable Historical Data

The historical data trend for China Biotech Services Holdings's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China Biotech Services Holdings Days Payable Chart

China Biotech Services Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Days Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 27.52 111.58 141.73 54.12 218.01

China Biotech Services Holdings Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Days Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 89.22 231.42 27.23 36.26 19.65

Competitive Comparison of China Biotech Services Holdings's Days Payable

For the Diagnostics & Research subindustry, China Biotech Services Holdings's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


China Biotech Services Holdings's Days Payable Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, China Biotech Services Holdings's Days Payable distribution charts can be found below:

* The bar in red indicates where China Biotech Services Holdings's Days Payable falls into.



China Biotech Services Holdings Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

China Biotech Services Holdings's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

Days Payable (A: Dec. 2023 )
=Average Accounts Payable /Cost of Goods Sold*Days in Period
=( (Accounts Payable (A: Dec. 2022 ) + Accounts Payable (A: Dec. 2023 )) / count ) / Cost of Goods Sold (A: Dec. 2023 )*Days in Period
=( (206.441 + 5.787) / 2 ) / 177.661*365
=106.114 / 177.661*365
=218.01

China Biotech Services Holdings's Days Payable for the quarter that ended in Dec. 2023 is calculated as:

Days Payable (Q: Dec. 2023 )
=Average Accounts Payable / Cost of Goods Sold*Days in Period
=( (Accounts Payable (Q: Sep. 2023 ) + Accounts Payable (Q: Dec. 2023 )) / count ) / Cost of Goods Sold (Q: Dec. 2023 )*Days in Period
=( (0 + 5.787) / 1 ) / 26.872*365 / 4
=5.787 / 26.872*365 / 4
=19.65

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


China Biotech Services Holdings Days Payable Related Terms

Thank you for viewing the detailed overview of China Biotech Services Holdings's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.


China Biotech Services Holdings (HKSE:08037) Business Description

Traded in Other Exchanges
N/A
Address
255-257 Gloucester Roaad, Suites 1904-05A, 19th Floor, Sino Plaza, Causeway Bay, Hong Kong, HKG
China Biotech Services Holdings Ltd is an investment holding company. It operates through six segments: Pharmaceutical Products, Medical and Health-Related Services, Immunotherapy, Securities, Insurance brokerage, BNCT and Others. It derives prime revenue from the Medical and health related services segment which involves the provision of medical laboratory testing and health check services. The group has a business presence in Hong Kong and the PRC, of which key revenue is generated from Hong Kong.
Executives
Liu Xiaolin 2101 Beneficial owner
Genius Earn Limited 2201 Interest of corporation controlled by you
Genius Lead Limited 2101 Beneficial owner
Guoyuan International Holdings Limited 2201 Interest of corporation controlled by you
Guoyuan Securities Co., Ltd. 2201 Interest of corporation controlled by you
Guoyuan Securities Investment (hong Kong) Limited 2101 Beneficial owner
Richlane Ventures Limited 2101 Beneficial owner
Ko Chun Shun, Johnson 2201 Interest of corporation controlled by you

China Biotech Services Holdings (HKSE:08037) Headlines

No Headlines